CSIMarket Company Name, Ticker, Competitors, else..


Century Therapeutics inc   (NASDAQ: IPSC)
Other Ticker:  
 

Century Therapeutics inc

IPSC's Fundamental analysis



Century Therapeutics Inc 's sales fell in the second quarter of 2025 from the same quarter a year ago. Ranking at No. 207

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.92 %

Century Therapeutics Inc net loss increased from $-31 millions, to $-33 millions in second quarter of 2025,

• More on IPSC's Growth


Century Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.38 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.45.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.13.


• More on IPSC's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 2.04

Century Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.38 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.45.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.13.

Century Therapeutics Inc Price to Book Ratio is at 0.25 lower than Industry Avg. of 2625.81. and higher than S&P 500 Avg. of 0.02

• More on IPSC's Valuation

•  Market Capitalization (Millions $) 52
•  Shares Outstanding (Millions) 86
•  Employees 107
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -23
•  Cash Flow (TTM) (Millions $) 15
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 2.04

•  Market Capitalization (Millions $) 52
•  Shares Outstanding (Millions) 86
•  Employees 107
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -23
•  Cash Flow (TTM) (Millions $) 15
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 10.72
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.43
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.